Why Biotech Just Had Its Best Week in Years—And Why This Rally Could Be Different

The ALPS Medical Breakthroughs ETF (SBIO) surged 91% over the past year, significantly outperforming the S&P 500. This growth was driven by sector-wide reflation and successful late-stage clinical cat...

Revolution Medicines shares surged following positive developments for its pancreatic-cancer drug candidate. Despite market speculation, a near-term acquisition appears unlikely, suggesting investors ...

Nvidia shares reached a record high, setting the stage for a critical week of trading. The stock's momentum faces a significant test as market participants evaluate whether the current valuation can s...